Back to top
more

Chemours (CC)

(Real Time Quote from BATS)

$25.57 USD

25.57
3,801,683

+0.01 (0.04%)

Updated Jun 14, 2024 09:46 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (91 out of 249)

Industry: Chemical - Diversified

Better trading starts here.

Zacks News

Chemours (CC) Lags Q3 Earnings and Revenue Estimates

Chemours (CC) delivered earnings and revenue surprises of -16.88% and 3.63%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

The Zacks Analyst Blog Highlights LyondellBasell, Chemours, Axalta Coating Systems and Ashland

LyondellBasell, Chemours, Axalta Coating Systems and Ashland are included in this Analyst Blog.

Anindya Barman headshot

4 Chemical Stocks Set to Pull Off a Beat This Earnings Season

While softer demand in certain end markets is likely to be a drag, LyondellBasell (LYB), Chemours (CC), Axalta Coating Systems (AXTA) and Ashland (ASH) are likely to have benefited from cost and pricing actions.

Why Chemours (CC) Could Beat Earnings Estimates Again

Chemours (CC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Earnings Preview: FMC (FMC) Q3 Earnings Expected to Decline

FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

How to Find Strong Basic Materials Stocks Slated for Positive Earnings Surprises

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Are Options Traders Betting on a Big Move in Chemours (CC) Stock?

Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.

Here's Why You Should Hold Onto Chemours (CC) Stock For Now

Chemours (CC) gains on strong execution, continued Opteon adoption and its efforts to reduce costs amid headwinds from demand weakness.

Chemours (CC) Benefits From Opteon Adoption Amid Demand Woes

Although Chemours (CC) is being challenged by softer demand in certain businesses, it gains on continued Opteon adoption, strong execution and its cost-reduction and pricing actions.

Here's Why You Should Retain Chemours (CC) in Your Portfolio

While Chemours (CC) is exposed to headwinds from demand softness in certain areas, it gains on continued Opteon adoption, strong execution and its cost-reduction and pricing actions.

Chemours (CC) Announces Development of New Specialty Fluid

Chemours' (CC) introduction of Opteon 2P50 is a critical step in positioning the company to meet a growing challenge brought on by a new era of data transmission.

Cabot (CBT) Joins US Energy Department's Better Plants Program

Cabot (CBT) believes that this engagement with the DOE will help the company boost its energy efficiency performance.

Chemours (CC) Q2 Earnings Beat, Titanium Technologies Hurt Sales

Chemours' (CC) Titanium Technologies sales were hurt by lower volumes due to weaker demand in all regions in Q2.

Methanex (MEOH) Beats Q2 Earnings and Revenue Estimates

Methanex (MEOH) delivered earnings and revenue surprises of 9.09% and 4.26%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Huntsman (HUN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Huntsman (HUN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Titanium Technologies Unit Hurt Chemours (CC) Q2 Earnings?

Slow demand recovery in the Titanium Technologies segment is expected to have weighed on Chemours' (CC) performance in the second quarter.

Earnings Preview: Chemours (CC) Q2 Earnings Expected to Decline

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Chemours (CC) Scales 52-Week High: What's Driving the Stock?

Chemours (CC) benefits from strong Opteon demand, effective execution, and its cost-reduction and pricing actions.

Chemours (CC) Stock Up 16% in 3 Months: What's Driving It?

Chemours (CC) gains on healthy Opteon demand, strong execution and its cost-reduction and pricing actions.

Chemours (CC) Gains on Opteon Adoption Amid Demand Woes

While Chemours (CC) is exposed to headwinds from demand softness in certain areas, it gains on continued Opteon adoption, strong execution and its cost-reduction and pricing actions.

Chemours (CC) to Divest Glycolic Acid Business to PureTech

Chemours (CC) believes that its Glycolic Acid portfolio complements PureTech's growth strategy.

Strength Seen in Chemours (CC): Can Its 24.1% Jump Turn into More Strength?

Chemours (CC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Here's Why You Should Hold Onto Chemours (CC) Stock for Now

While Chemours (CC) is exposed to headwinds from demand weakness in certain businesses, it gains on healthy Opteon adoption and its pricing actions.

Chemours (CC) Extends Capacity to Meet Customers' Needs

Chemours (CC) offers a portfolio of HFO-1336mzzZ-based products that are more environmentally friendly than non-HFO alternatives.